Sign up to save your podcasts
Or
Share 261 - Hearing Therapeutics in 2025: Where Are We, and What’s Next?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
261 - Hearing Therapeutics in 2025: Where Are We, and What’s Next?
Hearing therapeutics are advancing rapidly, but how close are we to real breakthroughs? That was the focus of The State of Hearing Therapeutics, a panel discussion held during the 2025 Hearing Therapeutics Summit on February 4.
Moderated by Brian Taylor, AuD, the panel featured Hugo Peris (Spiral Therapeutics), Tony Ricci, PhD (Stanford University School of Medicine), Jian Zuo, PhD (Ting Therapeutics), Dr. Douglas Hartley (Rinri Therapeutics), and Jonas Dyhrfjeld-Johnsen, PhD (Acousia Therapeutics).
The discussion provided a deep dive into the latest advancements in hearing restoration, including gene therapy, regenerative medicine, and pharmaceutical approaches to treating sensorineural hearing loss.
Panelists explored the current state of clinical research, regulatory pathways, and the challenges of bringing novel hearing therapeutics to market. They also discussed the growing role of precision medicine and targeted drug delivery in shaping the future of hearing healthcare. As scientific breakthroughs continue, collaboration across academia, industry, and clinical practice will be critical in accelerating the development of effective treatments.
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and X (formerly Twitter):
View all episodes
By This Week in Hearing
5
11 ratings
Hearing therapeutics are advancing rapidly, but how close are we to real breakthroughs? That was the focus of The State of Hearing Therapeutics, a panel discussion held during the 2025 Hearing Therapeutics Summit on February 4.
Moderated by Brian Taylor, AuD, the panel featured Hugo Peris (Spiral Therapeutics), Tony Ricci, PhD (Stanford University School of Medicine), Jian Zuo, PhD (Ting Therapeutics), Dr. Douglas Hartley (Rinri Therapeutics), and Jonas Dyhrfjeld-Johnsen, PhD (Acousia Therapeutics).
The discussion provided a deep dive into the latest advancements in hearing restoration, including gene therapy, regenerative medicine, and pharmaceutical approaches to treating sensorineural hearing loss.
Panelists explored the current state of clinical research, regulatory pathways, and the challenges of bringing novel hearing therapeutics to market. They also discussed the growing role of precision medicine and targeted drug delivery in shaping the future of hearing healthcare. As scientific breakthroughs continue, collaboration across academia, industry, and clinical practice will be critical in accelerating the development of effective treatments.
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and X (formerly Twitter):
More shows like This Week in Hearing
View all
Pivot
9,315 Listeners
The Daily
111,034 Listeners
The Indicator from Planet Money
9,511 Listeners
Interesting Times with Ross Douthat
6,907 Listeners
The Audiologist
2 Listeners
Hearing Matters Podcast
17 Listeners
The Ezra Klein Show
15,514 Listeners
The Weekly Show with Jon Stewart
10,626 Listeners